These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27903661)

  • 1. Risk assessment in pulmonary arterial hypertension.
    Raina A; Humbert M
    Eur Respir Rev; 2016 Dec; 25(142):390-398. PubMed ID: 27903661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification in pulmonary arterial hypertension.
    Weatherald J; Boucly A; Sitbon O
    Curr Opin Pulm Med; 2018 Sep; 24(5):407-415. PubMed ID: 30004992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and prognostic factors of decompensated pulmonary hypertension in the intensive care unit.
    Garcia MVF; Souza R; Costa ELV; Fernandes CJCS; Jardim CVP; Caruso P
    Respir Med; 2021 Dec; 190():106685. PubMed ID: 34823189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018.
    Leuchte HH; Ten Freyhaus H; Gall H; Halank M; Hoeper MM; Kaemmerer H; Kähler C; Riemekasten G; Ulrich S; Schwaiblmair M; Ewert R
    Int J Cardiol; 2018 Dec; 272S():20-29. PubMed ID: 30266353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
    Benza RL; Gomberg-Maitland M; Elliott CG; Farber HW; Foreman AJ; Frost AE; McGoon MD; Pasta DJ; Selej M; Burger CD; Frantz RP
    Chest; 2019 Aug; 156(2):323-337. PubMed ID: 30772387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Risk of Disease Progression in Pulmonary Arterial Hypertension: Insights from an International Survey of Clinical Practice.
    Simons JE; Mann EB; Pierozynski A
    Adv Ther; 2019 Sep; 36(9):2351-2363. PubMed ID: 31313097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis.
    Yogeswaran A; Gall H; Fünderich M; Wilkins MR; Howard L; Kiely DG; Lawrie A; Hassoun PM; Sirenklo Y; Torbas O; Sweatt AJ; Zamanian RT; Williams PG; Frauendorf M; Arvanitaki A; Giannakoulas G; Saleh K; Sabbour H; Cajigas HR; Frantz R; Al Ghouleh I; Chan SY; Brittain E; Annis JS; Pepe A; Ghio S; Orfanos S; Anthi A; Majeed RW; Wilhelm J; Ghofrani HA; Richter MJ; Grimminger F; Sahay S; Tello K; Seeger W;
    Chest; 2024 Sep; 166(3):585-603. PubMed ID: 38508334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease.
    Howard LS
    Eur Respir Rev; 2011 Dec; 20(122):236-42. PubMed ID: 22130816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre.
    Montani D; O'Callaghan DS; Jaïs X; Savale L; Natali D; Redzepi A; Hoette S; Parent F; Sitbon O; Simonneau G; Humbert M
    Eur Respir Rev; 2009 Dec; 18(114):272-90. PubMed ID: 20956152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy in pulmonary arterial hypertension.
    Olsson KM; Channick R
    Eur Respir Rev; 2016 Dec; 25(142):431-437. PubMed ID: 27903665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
    Aktaa S; Gale CP; Brida M; Giannakoulas G; Kovacs G; Adir Y; Benza RL; Böhm M; Coats A; D'Alto M; Escribano-Subias P; Ferrari P; Galiè N; Gibbs JSR; Gin-Sing W; Hoeper MM; Humbert M; Lang IM; Maron BA; Meszaros G; Vonk Noordegraaf A; Price LC; Pepke-Zaba J; Rådegran G; Reis A; Sitbon O; Torbicki A; Ulrich S; Rosenkranz S; Delcroix M
    Eur J Heart Fail; 2023 Apr; 25(4):469-477. PubMed ID: 36924171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction Models and Scores in Pulmonary Hypertension: A Review.
    Mouratoglou SA; Bayoumy AA; Noordegraaf AV
    Curr Pharm Des; 2021; 27(10):1266-1276. PubMed ID: 33155897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk stratification in pulmonary arterial hypertension - implementation of an internet-based risk calculator to guide treatment].
    Ahmed A; Ahmed S; Rådegran G
    Lakartidningen; 2023 Oct; 120():. PubMed ID: 37870224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
    Galiè N; Humbert M; Vachiery JL; Gibbs S; Lang I; Torbicki A; Simonneau G; Peacock A; Vonk Noordegraaf A; Beghetti M; Ghofrani A; Gomez Sanchez MA; Hansmann G; Klepetko W; Lancellotti P; Matucci M; McDonagh T; Pierard LA; Trindade PT; Zompatori M; Hoeper M;
    Eur Heart J; 2016 Jan; 37(1):67-119. PubMed ID: 26320113
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.
    Delcroix M; Staehler G; Gall H; Grünig E; Held M; Halank M; Klose H; Vonk-Noordegraaf A; Rosenkranz S; Pepke-Zaba J; Opitz CF; Gibbs JSR; Lange TJ; Tsangaris I; Huscher D; Pittrow D; Olsson KM; Hoeper MM
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension : A focussed review].
    Rosenkranz S
    Herz; 2023 Feb; 48(1):23-30. PubMed ID: 36648489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The study of risk in pulmonary arterial hypertension.
    Rubin LJ; Simonneau G; Badesch D; Galiè N; Humbert M; Keogh A; Massaro J; Matucci Cerinic M; Sitbon O; Kymes S
    Eur Respir Rev; 2012 Sep; 21(125):234-8. PubMed ID: 22941888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of serial right heart catheterization in risk stratification and management of pulmonary arterial hypertension.
    Sharma D; Shah RJ; Sreenivasan J; Kafle P; Gupta R; Levine A; Lanier GM; Aronow WS
    Expert Rev Cardiovasc Ther; 2022 Jul; 20(7):543-547. PubMed ID: 35726644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.